Related Experiment Video
Updated: May 12, 2026

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
Published on: August 19, 2014
Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks
Anthony G Uren1, Jaap Kool, Konstantin Matentzoglu
1Division of Molecular Genetics and Cancer Genomics Centre, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands.
Abstract:
p53 and p19(ARF) are tumor suppressors frequently mutated in human tumors. In a high-throughput screen in mice for mutations collaborating with either p53 or p19(ARF) deficiency, we identified 10,806 retroviral insertion sites, implicating over 300 loci in tumorigenesis. This dataset reveals 20 genes that are specifically mutated in either p19(ARF)-deficient, p53-deficient or wild-type mice (including Flt3, mmu-mir-106a-363, Smg6, and Ccnd3), as well as networks of significant collaborative and mutually exclusive interactions between cancer genes. Furthermore, we found candidate tumor suppressor genes, as well as distinct clusters of insertions within genes like Flt3 and Notch1 that induce mutants with different spectra of genetic interactions. Cross species comparative analysis with aCGH data of human cancer cell lines revealed known and candidate oncogenes (Mmp13, Slamf6, and Rreb1) and tumor suppressors (Wwox and Arfrp2). This dataset should prove to be a rich resource for the study of genetic interactions that underlie tumorigenesis.
Insights
This study identifies over 300 cancer-associated genes by screening for mutations collaborating with p53 or p19ARF tumor suppressors. The findings reveal complex genetic interactions and potential oncogenes/tumor suppressors across species.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- p53 and p19ARF are critical tumor suppressors frequently altered in human cancers.
- Understanding collaborative genetic events is crucial for cancer research.
Purpose of the Study:
- To identify genes and genetic interactions involved in tumorigenesis through a high-throughput screen.
- To uncover novel cancer genes and pathways by analyzing mutations collaborating with p53 or p19ARF deficiency.
Main Methods:
- A high-throughput retroviral insertion screen in mice was performed to identify collaborating mutations.
- Analysis of 10,806 retroviral insertion sites implicated over 300 genetic loci in tumorigenesis.
- Cross-species comparative analysis with human cancer cell line data was conducted.
Main Results:
- Identified 20 genes specifically mutated in p53- or p19ARF-deficient or wild-type mice, including Flt3, mmu-mir-106a-363, Smg6, and Ccnd3.
- Revealed networks of collaborative and mutually exclusive interactions between cancer genes.
- Discovered candidate tumor suppressor genes and identified distinct insertion clusters in Flt3 and Notch1, leading to varied genetic interactions.
- Cross-species analysis identified known and candidate human oncogenes (Mmp13, Slamf6, Rreb1) and tumor suppressors (Wwox, Arfrp2).
Conclusions:
- The identified dataset provides a rich resource for studying genetic interactions in tumorigenesis.
- This study highlights the complex interplay of genetic mutations in cancer development.
- Findings offer insights into potential therapeutic targets and biomarkers for cancer treatment.
Related Concept Videos
In vitro Mutagenesis
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

